257 related articles for article (PubMed ID: 27472713)
21. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.
Wang Y; Lin J; Cui J; Han T; Jiao F; Meng Z; Wang L
Oncotarget; 2017 Feb; 8(6):9354-9365. PubMed ID: 28030840
[TBL] [Abstract][Full Text] [Related]
23. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
Li BS; Liu H; Yang WL
Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
[TBL] [Abstract][Full Text] [Related]
24. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
25. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
Ma YB; Li GX; Hu JX; Liu X; Shi BM
Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
[TBL] [Abstract][Full Text] [Related]
26. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.
Liang QL; Wang BR; Chen GQ; Li GH; Xu YY
Med Oncol; 2010 Dec; 27(4):1164-70. PubMed ID: 19908168
[TBL] [Abstract][Full Text] [Related]
28. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
29. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
30. FoxQ1 is a Novel Molecular Target for Pancreatic Cancer and is Associated with Poor Prognosis.
Zhan HX; Xu JW; Wang L; Wu D; Zhang GY; Hu SY
Curr Mol Med; 2015; 15(5):469-77. PubMed ID: 26122655
[TBL] [Abstract][Full Text] [Related]
31. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
32. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
33. Expression of CD44 in pancreatic cancer and its significance.
Li XP; Zhang XW; Zheng LZ; Guo WJ
Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
[TBL] [Abstract][Full Text] [Related]
36. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance.
Zhou L; Wang MY; Liang ZY; Zhou WX; You L; Pan BJ; Liao Q; Zhao YP
Hum Pathol; 2016 Oct; 56():171-7. PubMed ID: 27346572
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
38. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
[TBL] [Abstract][Full Text] [Related]
39. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer.
Li X; Wang Z; Ma Q; Xu Q; Liu H; Duan W; Lei J; Ma J; Wang X; Lv S; Han L; Li W; Guo J; Guo K; Zhang D; Wu E; Xie K
Clin Cancer Res; 2014 Aug; 20(16):4326-38. PubMed ID: 24947933
[TBL] [Abstract][Full Text] [Related]
40. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]